See also this year's filing and all EDGAR filings for this company.
PDF Report 0000715446_2012_Anixa_Biosciences_Inc.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Large missing amount for aggregate "Assets" added to remainder. | industry.us_generic | {'missing_ratio': 1.649023326013602, 'aggregate_val': 8645832, 'exp_sum': 3263781, 'exp_to_value': {'AssetsCurrent': 3120357, 'IntangibleAssetsNetIncludingGoodwill': 0, 'PropertyPlantAndEquipmentNet': 15924, 'remainder_Assets': 127500}} |
Graph
Absolute values for 0000715446, Anixa Biosciences Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,120,357 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 15,924 |
| 3 | remainder_Assets | 5,509,551 |
| 4 | LiabilitiesCurrent | 2,105,148 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,872,605 |
| 9 | ResearchAndDevelopmentExpense | 3,124,773 |
| 10 | remainder_Expenses | 634,081 |
| 11 | remainder_Revenues | 1,003,193 |
| 12 | remainder_NetIncome | -1,749,770 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 8,645,832 |
| 1 | Liabilities | 2,105,148 |
| 2 | Expenses | 6,631,459 |
| 3 | Revenues | 1,003,193 |
| 4 | StockholdersEquity | 6,540,684 |
| 5 | NetIncome | -7,378,036 |
| 6 | ComprehensiveNetIncome | -7,378,036 |
| 7 | BaseVar | 10,067,701 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.28 |
| 9 | EconomicCapitalRatio | 2.52 |
Edgar->Model Mapping
Feature Distribution
